Symptoms of hypoglycemia include headache, dizziness, drowsiness, nervousness, confusion, tremor, nausea Aug 23, 2023 · PrandiMet contains a combination of metformin and repaglinide
See more Repaglinide causes your pancreas to release more insulin into the blood stream
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur
Interactions Adverse Reactions Warnings Monitoring Pregnancy Patient Education Boxed Warning Lactic acidosis: Postmarketing cases of metformin
Star 1 Summary Repaglinide is a antihyperglycemic used to improve glycemic control in diabetes
If thiazolidinedione and metformin do not result in adequate glycemic control, repaglinide may be added Starting dose and dose adjustments for combination therapy are the same
Side effects Interactions What is PrandiMet? PrandiMet contains a combination of metformin and repaglinide
Prescribed for Diabetes - Type 2
You may need a dose adjustment or more frequent monitoring of your blood sugar to safely use both medications
Using metFORMIN together with repaglinide can increase the risk of hypoglycemia, or low blood sugar
A dose of 6 mg/daily of repaglinide showed an efficacy comparable to 2 g of metformin on fasting and integrated 6-h post-prandial measures of plasma glucose, triglycerides and serum free fatty acids in 96 non-obese T2DM patients during a 4-month crossover study ; in a 24-week multicenter study 360 mg of nateglinide was similarly
Applies to: metformin / repaglinide and metformin / repaglinide Using metFORMIN together with repaglinide can increase the risk of hypoglycemia, or low blood sugar
Although certain medicines should not be used together at all, in other cases two different medicines may be used Drug interactions
Maximum daily dose: repaglinide 10 mg/metformin 2500 mg
If you need to have any type of x-ray or CT scan using a dye that is injected into your veins, you may need to temporarily
Alcohol may affect blood glucose levels in patients with diabetes
repaglinide, dapagliflozin
pioglitazone, repaglinide and rosiglitazone for CYP2C8, glibenclamide, glimepiride, glipizide, nateglinide and rosiglitazone for CYP2C9, suggesting an antagonistic interaction between metformin and gymnema
Repaglinide is used together with diet and exercise to treat high blood sugar (glucose) levels in patients with type 2 diabetes
Controlling high